SNAPC50 Activators encompass a range of chemical compounds that, through their distinct actions on various cellular signaling pathways, indirectly enhance the functional activity of SNAPC50, particularly in transcription regulation. Forskolin, by elevating cAMP levels, indirectly augments SNAPC50's role in transcription, as elevated cAMP affects transcription factors that could influence SNAPC50-mediated processes. Genistein and Sphingosine-1-phosphate, through tyrosine kinase inhibition and lipid signaling modulation respectively, also contribute to enhancing SNAPC50's functional role. They achieve this by shifting the balance of cellular signaling towards pathways where SNAPC50 is active, thus indirectly promoting its involvement in transcription regulation. Thapsigargin and A23187, by increasing intracellular calcium levels, affect calcium-dependent signaling pathways. This modulation can lead to the enhancement of SNAPC50's activity in transcription regulation, as calcium-sensitive transcription factors play a crucial role in these processes.
Further, the functional activity of SNAPC50 is influenced by compounds like Phorbol 12-myristate 13-acetate (PMA), LY294002, Wortmannin, SB203580, U0126, Staurosporine, and Epigallocatechin Gallate (EGCG), each contributing uniquely to its activation. PMA, through PKC activation, LY294002, and Wortmannin, as PI3K inhibitors, along with SB203580 and U0126 affecting the MAPK pathway, all indirectly enhance SNAPC50's role in transcription regulation by influencing key signaling pathways that intersect with transcriptional control. Staurosporine, a broad-spectrum kinase inhibitor, and EGCG, known for its multi-kinase inhibition property, further contribute to this enhancement by modulating kinase-dependent transcription pathways. Collectively, these SNAPC50 Activators, through their targeted effects on cellular signaling, facilitate the indirect enhancement of SNAPC50-mediated functions in transcription regulation, highlighting the intricate interplay between various signaling cascades and transcriptional control mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels. This elevation in cAMP can indirectly enhance the functional activity of SNAPC50, as cAMP-responsive elements may play a role in the transcriptional regulation of genes where SNAPC50 is involved. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting these kinases, it can shift the cellular signaling balance, indirectly enhancing the pathways where SNAPC50 is functionally active, particularly in transcription regulation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate operates in lipid signaling pathways. It can influence transcriptional regulation processes where SNAPC50 is active by altering lipid-mediated signaling cascades. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin increases intracellular calcium levels, affecting calcium-dependent signaling pathways. This can indirectly enhance SNAPC50's role in transcription regulation by modulating calcium-sensitive transcription factors. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can influence transcriptional regulation. SNAPC50, being involved in transcription, may be functionally enhanced due to the PKC-mediated signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, altering the PI3K/AKT pathway. This can lead to changes in transcription factor activities and indirectly enhance SNAPC50's functional role in transcriptional regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor. By affecting the PI3K/AKT pathway, it can modulate transcription factors and enhance SNAPC50's role in transcriptional regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, affecting MAPK signaling pathways. This inhibition can indirectly enhance SNAPC50's activity in transcription regulation due to the interplay of MAPK signaling with transcriptional processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK pathway. This can lead to an indirect enhancement of SNAPC50's functional role in transcription regulation, given the interconnectedness of these pathways with transcriptional control. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 increases intracellular calcium levels, which can influence calcium-dependent transcription factors, indirectly enhancing SNAPC50's role in transcription regulation. | ||||||